Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers

23 Dec 2021

Abstract excerpt

The CDKN2A (cyclin dependent kinase inhibitor 2A/multiple tumor suppressor 1) gene, also known as the P16 gene, encodes multiple tumor suppressor 1 ( MTS1 ), which belongs to the INK4 family. In tumor tissue, CDKN2A has a high expression level compared with normal tissue and reflects prognosis in tumor patients. Our research targeted the analysis of CDKN2A expression in 33 tumors and clinical parameters, patient...

Topics

Join the communities discussing this publication.

Cancer-related Molecular Pathways
Epigenetics and DNA Methylation
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35004697
DOI: 10.3389/fcell.2021.808208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple CancersPMID 35004697Read ↗

Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical OutcomeSemantic proximity Read ↗

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

Pancancer analysis of the interactions between CTNNB1 and infiltrating immune cell populations.Semantic proximity Read ↗

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer AnalysisSemantic proximity Read ↗

A multidimensional Pan-cancer analysis of CDKN1A identifies CDKN1A as an Immunological and Prognostic BiomarkerSemantic proximity Read ↗

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular CarcinomaSemantic proximity Read ↗

Cyclin B1: A potential prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

A Pan-Cancer Analysis Reveals OAS2 as a Biomarker for Cancer Prognosis and ImmunotherapySemantic proximity Read ↗

The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarkerSemantic proximity Read ↗

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-CancerSemantic proximity Read ↗

The epiphany derived from T-cell–inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.